Professional Documents
Culture Documents
25 AUG 2016
NESTLE INDIA
SELL
FMCG
CMP
Potential Upside
: Rs 6,825
: -12%
MARKET DATA
No. of Shares
Free Float
Market Cap
52-week High / Low
Avg. Daily vol. (6mth)
Bloomberg Code
Promoters Holding
FII / DII
: 96 mn
: 37%
: Rs 658 bn
: Rs 7,390 / Rs 4,990
: 45,219 shares
: NEST IB Equity
: 63%
: 0% / 6%
Way forward: Nestle aims to achieve its growth objective through (a) penetration and frequency, (b) consumer-focused
innovation and renovation, and (c) capturing potential of many Indias within India. Seven identified trends influencing
the companys way forward are(i) increasing urbanization, (ii) technology tide (~345 mn population is tech enabled),
(iii) increasing women power (decision making on the rise), (iv) premiumization, (v) valorizing value, (vi) quest for
goodness and (vii) balance between taste, indulgence and health.
Our view: Nestle delivered 18% EPS CAGR over CY01-11 led by 15% sales growth and margin gains. In the past five
years, volume growth slowed down with sales and EPS CAGR of 5% and 4% over CY11-16E (despite full Maggi sales
in CY16). We believe Nestle might deliver on growth expectations (~15% growth) over CY16-18E but it would be
mainly achieved due to lower base. It would be difficult to sustain this rate as baby food category(high contribution to
sales) is growing at a slower pace.
Key drivers
Y/E December
CY15
CY16E
CY17E
81,233
96,361
110,678
126,714
9,800
12,223
14,189
16,695
123.3
148.5
170.5
EPS (Rs)
101.6
126.8
147.2
173.2
(20.1)
24.7
16.1
17.7
P/E (x)
67.1
53.8
46.4
39.4
Price performance
RoE (%)
34.7
41.0
42.7
45.3
140
RoCE (%)
46.6
58.2
60.1
63.1
120
EV/E (x)
38.6
30.9
26.7
23.2
100
DPS (Rs)
48.5
75.0
90.0
110.0
80
CY18E
(%)
CY15E
CY16E
CY17E
(17.8)
20.2
15.5
(1.3)
0.8
7.8
Gross margin
57.3
57.5
57.2
EBITDA margin
20.3
21.3
21.3
Domestic Revenue
Growth
Exports Growth
Sensex
Nestle India
60
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
01
25 AUG 2016
NESTLE INDIA
FMCG
Rebound and reloaded While there was concern over revival of noodles
category due to Maggi controversy (from Jun-15 to Nov-15), Nestle India has
not lost any distributor, saw no industrial disputes and no supplier left
170
171
44%
148
136
129
131
54% 56%
57%
35%
138
100
Apr-16
Mar-16
Feb-16
Jan-16
Dec-15
Nov-15
Jun-16
May-16
Apr-16
Mar-16
Feb-16
Jan-16
11%
Dec-15
Nov-15
48%
51%
Jun-16
May-16
02
25 AUG 2016
NESTLE INDIA
FMCG
What is the new reality: Management is hopeful that urbanization can help
urban-biased companies. It highlighted sevenimportant trends for Nestle:
Propensity to premiumize:
premium products
Valorizing value: Indian consumer is looking for value-add and price is not
the only criteria for buying decisions
Quest for goodness: Huge opportunities exist in health and nutrition space.
Nestle Health Science business has strong prospects. Eg. ~63 mn peoplein
India arediabetic and the number has been rising through the years
Overall
market
is
moving
towards
Where does Nestle want to go: Company vision is to remain a leading and
trusted health and wellness company.Of the 1.28bn (in 2015) Indian
population, Nestle India is targeting urban-centric 315 mn population.
Management highlighted its key ambitions and growth drivers:
Winning edge: (a) fast, focused and flexible in thought and action,
(b) embrace powerful way of working and(c) enable, empower, engage,
and energize colleagues
03
25 AUG 2016
NESTLE INDIA
FMCG
Prepared dishes and cooking aidsThe company has expanded the Maggi
franchise with new launches like (a) Maggi Cuppanoodles (4 variants),
(b) Maggi Hot Heads (4 variants) and (c) Maggi no garlic and no onion. It is
focusing to uptradethrough these launches. Response has been good so far
Beverages New launches include NESCAF SUNRISE Insta-Filter, NESCAF 3in-1, NESCAF RTD 3 variants, NESTEA 3 variants
04
25 AUG 2016
NESTLE INDIA
FMCG
125
120
115
112
115
114
107
110
105
100
100
95
1HCY16
2015
2014
2013
2011
2012
90
Source: Company, Axis Capital Note: Indexed with base year 2011
150
160
170
150
140
140
130
130
120
120
110
110
100
100
Current
Q1CY16
Q3CY15
Q1CY15
Q3CY14
Q1CY14
Q3CY13
Q1CY13
Q3CY12
Q1CY12
Q3CY11
Q1CY11
90
Q3CY10
Current
Q1CY16
Q3CY15
Q1CY15
Q3CY14
Q1CY14
Q3CY13
Q1CY13
Q3CY12
Q1CY12
Q3CY11
Q1CY11
Q3CY10
Q1CY10
90
Q1CY10
160
05
25 AUG 2016
NESTLE INDIA
FMCG
90
Q1CY16
Current
Current
Q3CY15
Q1CY15
Q3CY14
Q1CY14
Q3CY13
Q1CY13
Q3CY12
Q1CY12
80
Q1CY16
200
180
220
180
160
160
140
140
120
120
100
Q3CY15
Q1CY15
Q3CY14
Q1CY14
Q3CY13
Q1CY13
Q3CY12
Q1CY12
Q3CY11
Q1CY11
80
Q3CY10
Current
Q1CY16
Q3CY15
Q1CY15
Q3CY14
Q1CY14
Q3CY13
Q1CY13
Q3CY12
Q1CY12
Q3CY11
Q1CY11
Q3CY10
80
Q1CY10
100
Q1CY10
100
Current
Q1CY16
Q3CY15
Q1CY15
Q3CY14
Q1CY14
Q3CY13
Q1CY13
Q3CY12
Q1CY12
Q3CY11
Q1CY11
Q3CY10
Q1CY10
70
110
Q3CY11
80
120
Q1CY11
90
130
Q3CY10
100
Q1CY10
110
Effective tax rate for H1CY16 increased 550 bps YoY to 36%(vs. 30.5% in
H1CY15). Management highlighted that lower tax rate in H1CY15 was due to
(a) investment allowance received was for couple of years and (b) profit from
tax holiday period was high. Management highlighted that tax benefit from
Pantnagar facility has been phased out effective 1st Apr 2016
06
25 AUG 2016
NESTLE INDIA
FMCG
60
10 yr median
50
40
30
20
Aug-16
Aug-15
Aug-14
Aug-13
Aug-12
Aug-11
Aug-10
Aug-09
Aug-08
Aug-07
Aug-06
10
07
25 AUG 2016
NESTLE INDIA
FMCG
CY16E
CY17E
CY18E
Y/E December
CY15
CY16E
CY17E
CY18E
81,233
96,361
110,678
126,714
14,155
18,380
21,021
24,361
520
617
682
754
(3,473)
(3,627)
(4,099)
(4,508)
81,753
96,978
111,360
127,468
(34,689)
(40,954)
(47,339)
(54,487)
47,064
56,025
64,021
72,981
57.9
58.1
57.8
57.6
(30,504)
(35,347)
(40,270)
(45,711)
16,560
20,678
23,751
27,271
20.4
21.5
21.5
21.5
Capital expenditure
Cash flow from investing
1,665
1,797
18,795
21,606
(944)
(5,692)
(6,000)
(6,250)
(4,974)
(1,075)
(6,631)
(6,652)
(18)
(177)
(8,533)
(10,239)
(12,515)
(12,362)
(9,310)
(10,889)
(13,165)
532
4,515
1,275
1,789
CY15
CY16E
CY17E
CY18E
101.6
126.8
147.2
173.2
CEPS (Rs)
94.4
160.3
185.1
215.3
48.5
75.0
90.0
110.0
83.0
61.2
63.1
65.3
(3,473)
(3,627)
(4,099)
(4,508)
EBIT
13,087
17,051
19,652
22,763
(33)
(39)
Other income
216
14,899
(5,633)
Dividend paid
Depreciation
Net interest
3,445
17,868
Key ratios
1,101
1,368
1,369
1,598
14,155
18,380
21,021
24,361
Y/E December
Total taxation
(4,356)
(6,157)
(6,832)
(7,666)
OPERATIONAL
30.8
33.5
32.5
31.5
9,800
12,223
14,189
16,695
FDEPS (Rs)
Minorities
DPS (Rs)
9,800
12,223
14,189
16,695
12.1
12.7
12.8
13.2
(17.2)
18.6
14.9
14.5
(4,167)
(399)
(439)
(445)
EBITDA (%)
(21.2)
24.9
14.9
14.8
(20.1)
24.7
16.1
17.7
FDEPS (%)
(20.1)
24.7
16.1
17.7
RoE (%)
34.7
41.0
42.7
45.3
RoCE (%)
46.6
58.2
60.1
63.1
6.2
8.8
9.2
10.5
5,633
11,824
13,750
16,249
GROWTH
PERFORMANCE
CY15
CY16E
CY17E
CY18E
964
964
964
964
27,214
30,505
34,017
37,751
EFFICIENCY
Net worth
28,178
31,470
34,981
38,715
Borrowing
177
1,729
1,729
1,729
1,729
Total liabilities
60,804
65,383
72,335
79,918
Receivable days
3.5
4.0
3.6
3.6
51,174
56,674
62,674
68,924
Inventory days
46.0
42.0
43.3
43.4
Less: Depreciation
(22,195)
(25,822)
(29,921)
(34,429)
Payable days
41.6
30.1
30.3
30.5
28,979
30,851
32,753
34,495
2,308
2,500
2,500
2,500
31,286
33,351
35,253
36,995
(0.6)
(0.7)
(0.7)
(0.7)
Total Investment
13,249
10,000
12,000
14,000
0.5
0.7
0.7
0.7
8,208
8,773
10,402
11,909
397.8
437.2
784
1,069
1,103
1,263
4,995
9,557
10,832
12,621
PE (x)
67.1
53.8
46.4
39.4
38.6
30.9
26.7
23.2
7.9
6.6
5.7
5.0
23.4
20.9
18.8
17.0
0.7
1.1
1.3
1.6
2.6
1.4
1.9
2.3
Inventory
Debtors
Cash & bank
Loans & advances
2,134
2,533
2,646
3,030
Current liabilities
30,719
32,184
35,625
39,473
(14,451)
(10,153)
(10,543)
(10,550)
60,804
65,383
72,335
79,918
1.4
1.5
1.6
1.7
(0.2)
(0.2)
(0.2)
(0.2)
FINANCIAL STABILITY
Total debt/ equity (x)
VALUATION
08
25 AUG 2016
NESTLE INDIA
FMCG
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the
Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial
products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of Indias largest private sector bank and
has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the
details in respect of which are available on www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the
Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance
business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately
reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or
indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the
subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the
end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial
service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies
mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director
/ officer, etc. in the subject company in the last 12-month period.
Research Team
Sr. No
Name
Designation
Sunil Shah
Head of Research
sunil.shah@axissecurities.in
PankajBobade
Research Analyst
pankaj.bobade@axissecurities.in
Priyakant Dave
Research Analyst
priyakant.dave@axissecurities.in
Akhand Singh
Research Analyst
akhand.singh@axissecurities.in
BuntyChawla
Research Analyst
bunty.chawla@axissecurities.in
Hiren Trivedi
Research Associate
hiren.trivedi@axissecurities.in
Kiran Gawle
Associate
kiran.gawle@axissecurities.in
5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for
the subject company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of
its associates may have:
i.
ii.
iii.
Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject
company of this research report and / or;
Managed or co-managed public offering of the securities from the subject company of this research report and / or;
Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject
company of this research report;
ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party
in connection with this report
Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is
strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or
reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct,
reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other
sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is
made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared
solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other
financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same
time. ASL will not treat recipients as customers by virtue of their receiving this report.
09
25 AUG 2016
NESTLE INDIA
FMCG
Disclaimer:
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate
to the recipients specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all
investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient.
This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such
investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report
(including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions,
including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for
all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to
the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the
currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance.
Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated
before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not
predictions and may be subject to change without notice.
ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of
the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a
market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such
company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of
these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document.
ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the
recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of
Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports
that are inconsistent with and reach different conclusion from the information presented in this report.
Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or
indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has
reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or
intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction,
where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing
requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of
investors.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as
endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be
required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the
views expressed therein.
Copyright in this document vests with Axis Securities Limited.
Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No.
18002100808/022-61480808, Regd. off.- Axis House, 8th Floor, Wadia International Centre, PandurangBudhkarMarg, Worli, Mumbai 400 025. Compliance
Officer: AnandShaha, Email: compliance.officer@axisdirect.in, Tel No: 022-42671582.
010